#us generics

1 story

#biologics #car-t therapy #glp-1 #oncology #saroglitazar #specialty medicines #zydus lifesciences

Zydus Targets New Growth Areas
Zydus Lifesciences plans to expand into specialty medicines and biologics while maintaining US generics.
The Economic Times · 1m